We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
Advanced Micro Devices
AMD
$851B
| $30.7M | 0.14% |
327,200
+74,100
| +29% | +$5.99M |
|
152
ExxonMobil
XOM
$651B
| $30.7M | 0.14% |
487,054
-285,739
| -37% | -$17.1M |
|
153
Star Bulk Carriers
SBLK
$3.14B
| $30.6M | 0.14% |
1,335,258
+176,384
| +15% | +$3.49M |
|
154
CALL
iShares Semiconductor ETF
SOXX
$44.2B
| $30.6M | 0.14% |
202,200
+199,500
| +7,389% | +$28.5M |
|
155
Analog Devices
ADI
$181B
| $30.6M | 0.14% |
+177,625
| New | +$28.5M |
|
156
DraftKings
DKNG
$11.4B
| $29.7M | 0.13% |
569,706
+213,273
| +60% | +$11.3M |
|
157
Universal Health Services
UHS
$9.43B
| $29.6M | 0.13% |
202,177
+110,765
| +121% | +$16.7M |
|
158
Blackstone
BX
$104B
| $29.5M | 0.13% |
303,857
+135,807
| +81% | +$12.1M |
|
|
KAHC
159
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $29.5M | 0.13% |
+2,999,484
| New | +$29.3M |
|
160
Boeing
BA
$165B
| $29.5M | 0.13% |
122,940
+25,381
| +26% | +$6.14M |
|
161
Procter & Gamble
PG
$343B
| $29.1M | 0.13% |
215,579
+157,285
| +270% | +$21.3M |
|
162
Ternium
TX
$9.29B
| $29M | 0.13% |
752,948
+62,393
| +9% | +$2.38M |
|
|
WORK
163
DELISTED
Slack Technologies, Inc.
WORK
| $28.9M | 0.13% |
653,036
-329,323
| -34% | -$14.1M |
|
164
GeneDx Holdings
WGS
$1.75B
| $28.6M | 0.13% |
61,773
| – | – |
|
165
Blackrock
BLK
$164B
| $28.3M | 0.13% |
32,296
-1,079
| -3% | -$911K |
|
166
W.P. Carey
WPC
$17.1B
| $28.1M | 0.13% |
384,968
+367,222
| +2,069% | +$26.9M |
|
167
Enbridge
ENB
$124B
| $27.8M | 0.13% |
694,223
-309,301
| -31% | -$12M |
|
168
Spotify
SPOT
$99.2B
| $27.8M | 0.13% |
100,782
+58,877
| +141% | +$14.9M |
|
169
Dentsply Sirona
XRAY
$2.59B
| $27.7M | 0.13% |
438,429
+343,924
| +364% | +$22.7M |
|
170
Oneok
OKE
$58.7B
| $27.6M | 0.12% |
495,858
+430,403
| +658% | +$22.9M |
|
171
Leslie's
LESL
$11.6M
| $27.6M | 0.12% |
+50,170
| New | +$27.5M |
|
172
PUT
iShares Silver Trust
SLV
$28.1B
| $27.5M | 0.12% |
1,134,300
+258,100
| +29% | +$6.39M |
|
|
XLNX
173
DELISTED
Xilinx Inc
XLNX
| $27.3M | 0.12% |
188,842
-177,200
| -48% | -$22.5M |
|
|
ASZ
174
DELISTED
Austerlitz Acquisition Corporation II
ASZ
| $27.3M | 0.12% |
+2,803,356
| New | +$27.5M |
|
175
British American Tobacco
BTI
$132B
| $26.4M | 0.12% |
672,005
+648,835
| +2,800% | +$25.4M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.